Funding for this research was provided by:
Wendel Jarlsbergs fund (na)
Mills DA (NA)
Received: 12 November 2019
Accepted: 8 May 2020
First Online: 21 May 2020
Ethics approval and consent to participate
: The study was approved by the Regional Committee of Medical Ethics (ref. 2013/1660). Written informed consent for participation was obtained, and the study complied with the Declaration of Helsinki.
: Not applicable.
: TO and TCNR declare that they have no competing interests. KS reports grants from Mills DA (Vita hjertego’) relevant for the present paper, and grants from a pharmacy interest organization (Stiftelsen til fremme av. norsk apotekfarmasi), personal fees from MedXplore outside the submitted work. SMU has received research grants from Tine DA, Mills DA, Olympic Seafood, none of which are related to the content of this manuscript. KBH reports grants from Tine SA, Mills DA, Olympic Seafood, Amgen, Sanofi, Kaneka and personal fees from Amgen, Sanofi, Pronova, outside the submitted work. KR reports personal fees from MedXplore, Amgen, Mills DA, The Norwegian Medical Association, The Norwegian Directorate of Health, Sanofi, Takeda, Chiesi, Bayer and MSD, outside the submitted work. VHTH is a former employee at Mills AS and reports grants from Mills AS. She does not owns any stocks in the company, and the work performed in this paper was done after she left the company.